Aptus Pharma Limited IPO
BBSMEBSEListed
Listed at
80.8
+15.43%
Aptus Pharma Limited IPO is a SME book building IPO. Issue size is 13.02 Cr. Price band is ₹65 to ₹70 per share. Minimum investment is ₹2.80 L. Lot size is 2000 shares. Open from 23 Sept 2025 to 25 Sept 2025. Allotment on 26 Sept 2025. Listing on 30 Sept 2025 at BSE. Managed by Interactive Financial Services Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Aptus Pharma Limited IPO overview
Aptus Pharma Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Price band
₹65 to ₹70
Lot size
2000 shares / lot
Min investment
₹2,80,000
Issue open – close
23 Sept 2025 → 25 Sept 2025
Aptus Pharma Limited IPO important dates
Issue Opens
23 Sept 2025
Issue Closes
25 Sept 2025
Allotment
26 Sept 2025
Listing
30 Sept 2025
Aptus Pharma Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 6,000 | ₹4,20,000 |
| S-HNI (UPI) | 3 | 6,000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 14,000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 16,000 | ₹11,20,000 |
Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.
Quick Profit Calculator for Aptus Pharma Limited IPO
Pre-filled: Issue Price = ₹70, Lot Size = 2,000 shares, Listing Price = ₹80.8
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,80,000 | ₹81 | +₹43,200 |
| S-HNI (Min) | 3 | ₹4,20,000 | ₹81 | +₹64,800 |
| S-HNI (UPI) | 3 | ₹4,20,000 | ₹81 | +₹64,800 |
| S-HNI (Max) | 7 | ₹9,80,000 | ₹81 | +₹1,51,200 |
| B-HNI (Min) | 8 | ₹11,20,000 | ₹81 | +₹1,72,800 |
Profit based on the official listing price for each investor category.
About Aptus Pharma Limited IPO
From the company / RHP narrative.
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.
Aptus CD care: Focused on chronic therapies
Aptus Wellcare: Offers wellness and nutraceutical products
Aptus Global: Export in overseas market
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Competitive Strengths
Diversified product portfolio
Robust distribution network
Strategic manufacturing alliances across Gujarat, Uttarakhand and Himachal Pradesh
Competitive and cost-effective pricing
Experienced management team
Aptus Pharma Limited IPO Issue Objective
How the issuer plans to use IPO proceeds.
Capital Expenditure for Office Premises with furniture and Industrial Racks
Working Capital
General corporate purposes
Aptus Pharma Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.
What is Aptus Pharma Limited IPO?
Aptus Pharma Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Aptus Pharma Limited IPO?
The IPO price band of Aptus Pharma Limited IPO is ₹₹65 to ₹70 per share, as mentioned in the issue details.
What is the minimum investment required for Aptus Pharma Limited IPO?
The minimum investment in Aptus Pharma Limited IPO is ₹2,80,000, based on the applicable lot size for retail investors.
What is the lot size of Aptus Pharma Limited IPO?
The lot size of Aptus Pharma Limited IPO is 2000 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Aptus Pharma Limited IPO?
Aptus Pharma Limited IPO opens on 23 Sept 2025 and closes on 25 Sept 2025, as per the announced schedule.
What is Aptus Pharma Limited IPO subscription status?
Aptus Pharma Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Aptus Pharma Limited IPO GMP today?
Aptus Pharma Limited IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.
Is Aptus Pharma Limited IPO GMP positive or negative?
Aptus Pharma Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Aptus Pharma Limited IPO GMP indicate for listing?
A positive Aptus Pharma Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Aptus Pharma Limited IPO listing date?
The expected listing date of Aptus Pharma Limited IPO is 30 Sept 2025, subject to completion of the allotment process.
Where can I check Aptus Pharma Limited IPO allotment status?
Aptus Pharma Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Aptus Pharma Limited IPO subscription and GMP change before listing?
Yes, Aptus Pharma Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.
Aptus Pharma Limited IPO Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Loading ratings…